{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-018910","form_type":"8-K","ticker":null,"cik":"0001839133","company_name":"IR-Med, Inc.","filed_at":"2023-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.058750+00:00","generated_at":"2026-06-14T16:09:51.643000+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CEO Moshe Gerber resigns; Chairperson Oded Bashan named Interim CEO","bullets":["Moshe Gerber resigned as CEO of IR-Med, Inc. and its Israeli subsidiary, effective May 21, 2023.","Resignation is not due to any disagreement with the company or its auditors.","Gerber will remain available until August 19, 2023, receiving salary and benefits through August.","Accelerated vesting of 433,333 stock options at $0.32/share, exercisable through Dec 31, 2030.","Upon compliance, Gerber receives an additional 21,000 NIS (~$5,780) at end of notice period."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-018910","json":"https://secwatch.observer/filing/0001493152-23-018910.json","markdown":"https://secwatch.observer/filing/0001493152-23-018910.md","text":"https://secwatch.observer/filing/0001493152-23-018910.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1839133/000149315223018910/0001493152-23-018910-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1839133/000149315223018910/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T16:09:51.643000+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eb28ffba0f","claim":"Moshe Gerber resigned as Chief Executive Officer at IR-Med, Inc..","evidence_excerpt":"pursuant to which MG resigned from his role as Chief Executive Officer of the Companies.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1839133/000149315223018910/0001493152-23-018910-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"f7d6a8727c","claim":"Oded Bashan was appointed as Interim Chief Executive Officer at IR-Med, Inc..","evidence_excerpt":"Mr. Oded Bashan, the Chairperson and a co-founder of the Company, was appointed as Interim Chief Executive Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1839133/000149315223018910/0001493152-23-018910-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}